![Gregory Weaver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Weaver
Finanzdirektor/CFO bei
ALTIMMUNE, INC.
Vermögen: 116 138 $ am 31.05.2026
Profil
Gregory L.
Weaver is currently Director at BioIntelliSense, Inc., Director at Harborpath, Inc., Director at Centenara Labs AG, and Chief Financial & Accounting Officer at Altimmune, Inc. Former roles include Director at SCOLR Pharma, Inc.; Chief Financial Officer, Director & Executive VP at Atossa Therapeutics, Inc.; Independent Director at Zyla Life Sciences LLC; Chief Financial Officer, Secretary & VP at MDRNA, Inc.; Chief Financial Officer at Poniard Pharmaceuticals, Inc.; Chief Financial Officer & Senior Vice President at Sirna Therapeutics, Inc.; CFO, Secretary, Treasurer & Senior Vice President at Fibrocell Science, Inc.; Chief Financial Officer & Senior Vice President at Imunon, Inc.; Chief Financial Officer at ILEX Oncology, Inc.; Chief Financial Officer at Sevion Therapeutics, Inc.; Chief Financial Officer at Liminal BioSciences, Inc.; Global Chief Financial Officer & Executive VP at Oryzon Genomics SA; Chief Financial Officer at Prism Technologies, Inc.; Chief Financial Officer at Verity Solutions Group, Inc.; Chief Financial Officer at Oncology, Inc.; Member-Supervisory Board at TME Pharma NV; Chief Financial & Accounting Officer at Eloxx Pharmaceuticals, Inc.; Chief Financial Officer at Atai Beckley NV; and Chief Financial Officer at Cognito Therapeutics, Inc. Education includes undergraduate studies at Trinity University and an MBA from Boston College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALTIMMUNE, INC. 0.02% | 01.04.2026 | 38’078 ( 0.02% ) | 116 138 $ | 31.05.2026 |
Aktive Positionen von Gregory Weaver
| Unternehmen | Position | Beginn |
|---|---|---|
| ALTIMMUNE, INC. | Finanzdirektor/CFO | 11.11.2024 |
Rejuveron Life Sciences AG
 Rejuveron Life Sciences AG Investment ManagersFinance Functions as an alternative investment manager | Direktor/Vorstandsmitglied | - |
BioIntelliSense, Inc.
 BioIntelliSense, Inc. Packaged SoftwareTechnology Services Develops health monitoring and clinical intelligence for remote patient monitoring | Direktor/Vorstandsmitglied | 01.06.2023 |
Harborpath, Inc.
 Harborpath, Inc. Harborpath, Inc. is a national nonprofit healthcare organization that provides uninsured and vulnerable patients with free medications for conditions such as opioid overdose, cancer, and chronic diseases. The private company is based in Charlotte. The organization streamlines access to these drugs through a simplified, HIPAA-compliant application process, partners with pharmaceutical manufacturers, healthcare providers, states, and nonprofits, and supports communities affected by the opioid and fentanyl epidemic. Harborpath also conducts education campaigns, supplies naloxone to first responders and students, and offers oncology patient assistance programs. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Gregory Weaver
| Unternehmen | Position | Ende |
|---|---|---|
Cognito Therapeutics, Inc.
 Cognito Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with neurodegenerative diseases | Finanzdirektor/CFO | 01.06.2024 |
| ATOSSA THERAPEUTICS, INC. | Finanzdirektor/CFO | 05.10.2023 |
| TME PHARMA N.V. | Direktor/Vorstandsmitglied | 30.09.2022 |
ATAI Life Sciences NV
 ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Finanzdirektor/CFO | 16.08.2022 |
| ELOXX PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 15.03.2020 |
Ausbildung von Gregory Weaver
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
25
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 25 |
|---|---|
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services Researches, develops, manufactures and commercializes nasally administered forms of pharmaceuticals | Commercial Services |
Poniard Pharmaceuticals, Inc.
 Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Commercial Services |
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology Develops drugs to treat and prevent cancer | Health Technology |
Trinity University
 Trinity University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SCOLR Pharma, Inc.
 SCOLR Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel prescription pharmaceutical, over-the-counter and nutritional products | Health Technology |
Sevion Therapeutics, Inc.
 Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic technology for agricultural and medical applications | Commercial Services |
Liminal BioSciences, Inc.
 Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for patients with acute and chronic pain | Health Technology |
Oryzon Genomics SA
 Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
Prism Technologies, Inc.
 Prism Technologies, Inc. Packaged SoftwareTechnology Services Provides ebusiness enterprise solutions | Technology Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verity Solutions Group, Inc.
 Verity Solutions Group, Inc. Packaged SoftwareTechnology Services Provides automated medication management systems to acute care hospital pharmacies | Technology Services |
Oncology, Inc.
 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Provides oncology treatment information | Commercial Services |
TME Pharma NV
 TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Altimmune, Inc.
 Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
BioIntelliSense, Inc.
BioIntelliSense, Inc. Packaged SoftwareTechnology Services Develops health monitoring and clinical intelligence for remote patient monitoring | Technology Services |
Cognito Therapeutics, Inc.
Cognito Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with neurodegenerative diseases | Health Technology |
Rejuveron Life Sciences AG
Rejuveron Life Sciences AG Investment ManagersFinance Functions as an alternative investment manager | Finance |
Harborpath, Inc.
Harborpath, Inc. Harborpath, Inc. is a national nonprofit healthcare organization that provides uninsured and vulnerable patients with free medications for conditions such as opioid overdose, cancer, and chronic diseases. The private company is based in Charlotte. The organization streamlines access to these drugs through a simplified, HIPAA-compliant application process, partners with pharmaceutical manufacturers, healthcare providers, states, and nonprofits, and supports communities affected by the opioid and fentanyl epidemic. Harborpath also conducts education campaigns, supplies naloxone to first responders and students, and offers oncology patient assistance programs. | |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
